It was also detailed in a report from "*" although hidden in a section on most interesting director purchases 2019. Apparently they also ran a review oct 13 2019. You've probably already heared of these but just in case.
https://unauthorised investment advice/health/dr-borehams-crucible-recce-pharmaceuticals-the-emerging-superbug-killer/
https://unauthorised investment advice/director-trades/the-most-noteworthy-directors-trades-of-2019/
It was also detailed in a report from "*" although...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
-0.020(3.23%) |
Mkt cap ! $122.3M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 58.0¢ | $30.77K | 51.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 17599 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
59.5¢ |
Change
-0.020 ( 2.46 %) |
||||
| Open | High | Low | Volume | ||
| 58.5¢ | 59.5¢ | 58.0¢ | 25074 | ||
| Last updated 15.53pm 21/05/2024 ? | |||||
| RCE (ASX) Chart |